Viser 1 - 50 av 158 resultater
Tid Selskap Tittel Sektor Kategori
08 Nov 2024
15:18 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Mandatory Notification of Trade by Closely Associated Party of a Primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Nov 2024
15:10 CET
NYKODE THERAPEUTICS ASA Disclosure of large shareholding in Nykode Therapeutics ASA 20103010 Biotechnology Major shareholding notifications
08 Nov 2024
00:15 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – Webcast Invitation 20103010 Biotechnology Non-regulatory press releases
07 Nov 2024
23:25 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Regain Control of VB10.NEO Program 20103010 Biotechnology Inside information
06 Nov 2024
17:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at PEGS Europe 20103010 Biotechnology Non-regulatory press releases
27 Sep 2024
08:11 CEST
NYKODE THERAPEUTICS ASA Major shareholding notification 20103010 Biotechnology Major shareholding notifications
21 Aug 2024
16:20 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Aug 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q2 2024 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
21 Aug 2024
06:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Strategic Repositioning of VB10.16 to Focus on Locally Advanced Cervical Cancer and Recurrent Metastatic Head and Neck Cancer 20103010 Biotechnology Inside information
14 Aug 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Issuance of Key Patent Covering Individualized Neoantigen Based Vaccines 20103010 Biotechnology Non-regulatory press releases
01 Aug 2024
08:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q2 2024 financial results presentation 20103010 Biotechnology Non-regulatory press releases
01 Jul 2024
20:20 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Grant of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
20 Jun 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting 20103010 Biotechnology Non-regulatory press releases
11 Jun 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy 20103010 Biotechnology Non-regulatory press releases
24 May 2024
17:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Grant of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
16 May 2024
11:46 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 May 2024
07:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
14 May 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q1 2024 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
07 May 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q1 2024 financial results presentation 20103010 Biotechnology Non-regulatory press releases
25 Apr 2024
07:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Apr 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
19 Apr 2024
06:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Annual Report 2023 20103010 Biotechnology Annual financial and audit Reports
26 Mar 2024
15:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Mar 2024
19:38 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Mar 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
19 Mar 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases 20103010 Biotechnology Non-regulatory press releases
13 Mar 2024
14:57 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Mar 2024
16:16 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Mar 2024
13:31 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
04 Mar 2024
13:11 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
29 Feb 2024
16:27 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
28 Feb 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q4 2023 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Feb 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q4 2023 financial results presentation 20103010 Biotechnology Non-regulatory press releases
19 Dec 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
18 Dec 2023
21:19 CET
NYKODE THERAPEUTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Dec 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to Reduce the Burden of Colorectal Cancer 20103010 Biotechnology Non-regulatory press releases
07 Dec 2023
18:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
28 Nov 2023
10:49 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
24 Nov 2023
18:20 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – Primary insider transaction 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Nov 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q3 2023 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
10 Nov 2023
17:13 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
09 Nov 2023
08:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q3 2023 financial results presentation 20103010 Biotechnology Non-regulatory press releases
07 Nov 2023
08:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at Jefferies Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
31 Oct 2023
15:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
31 Oct 2023
14:41 CET
NYKODE THERAPEUTICS ASA Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
31 Oct 2023
09:16 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – New Share Capital Registered 20103010 Biotechnology Total number of voting rights and capital
30 Oct 2023
23:29 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – Subsequent Offering Cancelled 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Oct 2023
16:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
17:22 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
15:32 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders